Abstract
Background Trimethoprim-sulfamethoxazole (TMP-SMX) is a broad spectrum antimicrobial agent and also reduces the mortality among adults and children when used as prophylaxis against opportunistic infections in HIV infected patients. Drug resistant to TMP-SMX along with Extended spectrum b-lactamase (ESBL) production among Enterobacteriaceae is creating major therapeutic problem in clinical settings for treating the bacterial infections among HIV individuals.
Highlights
Trimethoprim-sulfamethoxazole (TMP-SMX) is a broad spectrum antimicrobial agent and reduces the mortality among adults and children when used as prophylaxis against opportunistic infections in HIV infected patients
also reduces the mortality among adults and children when used as prophylaxis against opportunistic infections
bacterial strains were isolated from HIV patients
Summary
Marimuthu Ragavan Rameshkumar[1], Nallusamy Vijaykanth[1], Ramachandran Vignesh[2], Pachamuthu Balakrishnan[2], Suniti Solomon[2], Narasingam Arunagirinathan1*. From 2nd International Science Symposium on HIV and Infectious Diseases (HIV SCIENCE 2014) Chennai, India. From 2nd International Science Symposium on HIV and Infectious Diseases (HIV SCIENCE 2014) Chennai, India. 30 January - 1 February 2014
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
